Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix net income
Net income is the profit left for shareholders after every expense, interest and tax.
Agentix's net income for the twelve months ending Jun 30, 2026 was -$417.49K. For fiscal 2026 it was -$485.64K. The highest annual figure on record is -$132.65K in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$485.64K | – |
| FY2025 | Mar 31, 2025 | -$567.05K | – |
| FY2024 | Mar 31, 2024 | -$585.15K | – |
| FY2021 | Aug 31, 2021 | -$1.34M | – |
| FY2019 | Aug 31, 2019 | -$132.65K | – |
| FY2018 | Aug 31, 2018 | -$42.79M | – |
| FY2017 | Aug 31, 2017 | -$381.10K | – |
| FY2016 | Aug 31, 2016 | -$295.64K | – |
| FY2015 | Aug 31, 2015 | -$175.13K | – |
| FY2014 | Aug 31, 2014 | -$208.88K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$117.67K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$77.11K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$78.60K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$144.11K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$185.82K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$181.77K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$143.89K | -2357.5% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$90.67K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$150.72K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$3.00K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $6.37K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$178.97K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$409.56K | – |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -$243.43K | – |
| Q3 FY2021CQ2 2021 | May 31, 2021 | -$173.24K | – |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | -$707.07K | – |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | -$216.71K | – |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | -$363.91K | – |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -$1.29M | – |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -$11.80K | – |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -$9.56K | – |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -$16.63K | – |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -$31.93K | – |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -$38.77K | – |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -$45.32K | – |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -$31.77K | – |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -$42.68M | – |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -$48.26K | – |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -$32.74K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -$56.85K | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -$38.49K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -$155.51K | -45307.3% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -$130.24K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -$116.20K | – |
| Q3 FY2016CQ2 2016 | May 31, 2016 | -$179.43K | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $344 | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | -$349 | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | -$25.06K | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | -$15.26K | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | -$76.70K | – |
See a number that looks wrong?